Literature DB >> 23273200

Structural and biochemical basis for the difference in the helicase activity of two different constructs of SARS-CoV helicase.

A O Adedeji1, K Singh, S G Sarafianos.   

Abstract

The non—structural protein 13 (nsp13) of Severe Acute Respiratory Syndrome Coronavirus (SARSCoV) is a helicase that separates double—stranded RNA or DNA with a 5'—3' polarity, using the energy of nucleotide hydrolysis. We have previously determined the minimal mechanism of helicase function by nsp13 where we demonstrated that the enzyme unwinds nucleic acid in discrete steps of 9.3 base—pairs each with a catalytic rate of 30 steps per second. In that study we used different constructs of nsp13 (GST and H6 constructs). GST—nsp13 showed much more efficient nucleic acid unwinding than the H6—tagged counterpart. At 0.1 second, more than 50% of the ATP is hydrolyzed by GST—nsp13 compared to less than 5% ATP hydrolysis by H6—nsp13. Interestingly, the two constructs have the same binding affinity for nucleic acids. We, therefore propose that the difference in the catalytic efficiency of these two constructs is due to the interference of ATP binding by the histidine tag at the amino—terminus of nsp13.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23273200      PMCID: PMC3612351     

Source DB:  PubMed          Journal:  Cell Mol Biol (Noisy-le-grand)        ISSN: 0145-5680            Impact factor:   1.770


  55 in total

Review 1.  A general model for nucleic acid helicases and their "coupling" within macromolecular machines.

Authors:  P H von Hippel; E Delagoutte
Journal:  Cell       Date:  2001-01-26       Impact factor: 41.582

2.  The Srs2 helicase prevents recombination by disrupting Rad51 nucleoprotein filaments.

Authors:  Xavier Veaute; Josette Jeusset; Christine Soustelle; Stephen C Kowalczykowski; Eric Le Cam; Francis Fabre
Journal:  Nature       Date:  2003-05-15       Impact factor: 49.962

3.  Viral replicase gene products suffice for coronavirus discontinuous transcription.

Authors:  V Thiel; J Herold; B Schelle; S G Siddell
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

4.  The Genome sequence of the SARS-associated coronavirus.

Authors:  Marco A Marra; Steven J M Jones; Caroline R Astell; Robert A Holt; Angela Brooks-Wilson; Yaron S N Butterfield; Jaswinder Khattra; Jennifer K Asano; Sarah A Barber; Susanna Y Chan; Alison Cloutier; Shaun M Coughlin; Doug Freeman; Noreen Girn; Obi L Griffith; Stephen R Leach; Michael Mayo; Helen McDonald; Stephen B Montgomery; Pawan K Pandoh; Anca S Petrescu; A Gordon Robertson; Jacqueline E Schein; Asim Siddiqui; Duane E Smailus; Jeff M Stott; George S Yang; Francis Plummer; Anton Andonov; Harvey Artsob; Nathalie Bastien; Kathy Bernard; Timothy F Booth; Donnie Bowness; Martin Czub; Michael Drebot; Lisa Fernando; Ramon Flick; Michael Garbutt; Michael Gray; Allen Grolla; Steven Jones; Heinz Feldmann; Adrienne Meyers; Amin Kabani; Yan Li; Susan Normand; Ute Stroher; Graham A Tipples; Shaun Tyler; Robert Vogrig; Diane Ward; Brynn Watson; Robert C Brunham; Mel Krajden; Martin Petric; Danuta M Skowronski; Chris Upton; Rachel L Roper
Journal:  Science       Date:  2003-05-01       Impact factor: 47.728

5.  Mechanisms and enzymes involved in SARS coronavirus genome expression.

Authors:  Volker Thiel; Konstantin A Ivanov; Ákos Putics; Tobias Hertzig; Barbara Schelle; Sonja Bayer; Benedikt Weißbrich; Eric J Snijder; Holger Rabenau; Hans Wilhelm Doerr; Alexander E Gorbalenya; John Ziebuhr
Journal:  J Gen Virol       Date:  2003-09       Impact factor: 3.891

6.  Coronavirus as a possible cause of severe acute respiratory syndrome.

Authors:  J S M Peiris; S T Lai; L L M Poon; Y Guan; L Y C Yam; W Lim; J Nicholls; W K S Yee; W W Yan; M T Cheung; V C C Cheng; K H Chan; D N C Tsang; R W H Yung; T K Ng; K Y Yuen
Journal:  Lancet       Date:  2003-04-19       Impact factor: 79.321

7.  Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study.

Authors:  J S M Peiris; C M Chu; V C C Cheng; K S Chan; I F N Hung; L L M Poon; K I Law; B S F Tang; T Y W Hon; C S Chan; K H Chan; J S C Ng; B J Zheng; W L Ng; R W M Lai; Y Guan; K Y Yuen
Journal:  Lancet       Date:  2003-05-24       Impact factor: 79.321

8.  Lung pathology of fatal severe acute respiratory syndrome.

Authors:  John M Nicholls; Leo L M Poon; Kam C Lee; Wai F Ng; Sik T Lai; Chung Y Leung; Chung M Chu; Pak K Hui; Kong L Mak; Wilina Lim; Kin W Yan; Kwok H Chan; Ngai C Tsang; Yi Guan; Kwok Y Yuen; J S Malik Peiris
Journal:  Lancet       Date:  2003-05-24       Impact factor: 79.321

9.  Epidemiological determinants of spread of causal agent of severe acute respiratory syndrome in Hong Kong.

Authors:  Christl A Donnelly; Azra C Ghani; Gabriel M Leung; Anthony J Hedley; Christophe Fraser; Steven Riley; Laith J Abu-Raddad; Lai-Ming Ho; Thuan-Quoc Thach; Patsy Chau; King-Pan Chan; Tai-Hing Lam; Lai-Yin Tse; Thomas Tsang; Shao-Haei Liu; James H B Kong; Edith M C Lau; Neil M Ferguson; Roy M Anderson
Journal:  Lancet       Date:  2003-05-24       Impact factor: 79.321

10.  Clinical presentations and outcome of severe acute respiratory syndrome in children.

Authors:  K L E Hon; C W Leung; W T F Cheng; P K S Chan; W C W Chu; Y W Kwan; A M Li; N C Fong; P C Ng; M C Chiu; C K Li; J S Tam; T F Fok
Journal:  Lancet       Date:  2003-05-17       Impact factor: 79.321

View more
  8 in total

1.  Evaluation of SSYA10-001 as a replication inhibitor of severe acute respiratory syndrome, mouse hepatitis, and Middle East respiratory syndrome coronaviruses.

Authors:  Adeyemi O Adedeji; Kamalendra Singh; Ademola Kassim; Christopher M Coleman; Ruth Elliott; Susan R Weiss; Matthew B Frieman; Stefan G Sarafianos
Journal:  Antimicrob Agents Chemother       Date:  2014-05-19       Impact factor: 5.191

2.  Homology Modeling and Protein Interaction Map of CHRNA7 Neurogenesis Protein.

Authors:  Ruchi Yadav; Deepshikha Deepshikha; Prachi Srivastava
Journal:  Ann Neurosci       Date:  2017-07-24

3.  Abelson Kinase Inhibitors Are Potent Inhibitors of Severe Acute Respiratory Syndrome Coronavirus and Middle East Respiratory Syndrome Coronavirus Fusion.

Authors:  Christopher M Coleman; Jeanne M Sisk; Rebecca M Mingo; Elizabeth A Nelson; Judith M White; Matthew B Frieman
Journal:  J Virol       Date:  2016-09-12       Impact factor: 5.103

4.  Antiviral Activity of Chitosan Nanoparticles Encapsulating Curcumin Against Hepatitis C Virus Genotype 4a in Human Hepatoma Cell Lines.

Authors:  Samah A Loutfy; Mostafa H Elberry; Khaled Yehia Farroh; Hossam Taha Mohamed; Aya A Mohamed; ElChaimaa B Mohamed; Ahmed Hassan Ibrahim Faraag; Shaker A Mousa
Journal:  Int J Nanomedicine       Date:  2020-04-22

5.  Bisindolylmaleimide IX: A novel anti-SARS-CoV2 agent targeting viral main protease 3CLpro demonstrated by virtual screening pipeline and in-vitro validation assays.

Authors:  Yash Gupta; Dawid Maciorowski; Samantha E Zak; Krysten A Jones; Rahul S Kathayat; Saara-Anne Azizi; Raman Mathur; Catherine M Pearce; David J Ilc; Hamza Husein; Andrew S Herbert; Ajay Bharti; Brijesh Rathi; Ravi Durvasula; Daniel P Becker; Bryan C Dickinson; John M Dye; Prakasha Kempaiah
Journal:  Methods       Date:  2021-01-14       Impact factor: 3.608

Review 6.  RNA helicases required for viral propagation in humans.

Authors:  John C Marecki; Binyam Belachew; Jun Gao; Kevin D Raney
Journal:  Enzymes       Date:  2021-11-02

Review 7.  Structure and Function of Major SARS-CoV-2 and SARS-CoV Proteins.

Authors:  Ritesh Gorkhali; Prashanna Koirala; Sadikshya Rijal; Ashmita Mainali; Adesh Baral; Hitesh Kumar Bhattarai
Journal:  Bioinform Biol Insights       Date:  2021-06-22

Review 8.  What we know but do not understand about nidovirus helicases.

Authors:  Kathleen C Lehmann; Eric J Snijder; Clara C Posthuma; Alexander E Gorbalenya
Journal:  Virus Res       Date:  2014-12-08       Impact factor: 3.303

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.